menu
    • menu

    Company profile for Sprout Pharma

    NEW Drugs in Dev: 1
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We’re committed to breakthrough firsts in women’s sexual health. Novel ideas fuel our entrepreneurial passion. At Sprout, we celebrate ownership, boldness, quirkiness, learning, family and appreciation. They are central to what we stand for and what we’re trying to collectively accomplish.We were acquired by Valeant for $1B in 2015. Two years later, in an unprecedented move, our CEO Cindy Eckert and her shareholders re-...
    We’re committed to breakthrough firsts in women’s sexual health. Novel ideas fuel our entrepreneurial passion. At Sprout, we celebrate ownership, boldness, quirkiness, learning, family and appreciation. They are central to what we stand for and what we’re trying to collectively accomplish.We were acquired by Valeant for $1B in 2015. Two years later, in an unprecedented move, our CEO Cindy Eckert and her shareholders re-acquired Sprout. We’ve since relaunched our product at a price that strives to ensure more women have access.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sprout PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4208 Six Forks Rd, Suite 1010, Raleigh, North Carolina 27609
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sproutpharmaceuticals.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Time Names Addyi Maker Sprout Pharma to 2026 Top 10
    Time Names Addyi Maker Sprout Pharma to 2026 Top 10

    29 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sprout-pharmaceuticals-makers-of-addyi-flibanserin-named-one-of-the-10-most-influential-health-and-life-science-companies-of-2026-by-time-302757517.html

    PR NEWSWIRE
    29 Apr 2026
    Share Share
    PHIL And Sprout Pharma Enhance Addyi Access Program
    PHIL And Sprout Pharma Enhance Addyi Access Program

    08 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phil-and-sprout-pharmaceuticals-expand-their-affordable-direct-to-patient-access-program-for-addyiflibanserin-302655793.html

    PR NEWSWIRE
    08 Jan 2026
    Share Share
    FDA Approves Addyi For Postmenopausal Women's Sexual Health
    FDA Approves Addyi For Postmenopausal Women's Sexual Health

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/historic-first-in-womens-sexual-health-fda-grants-approval-for-addyi-flibanserin-in-postmenopausal-women-302642397.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    Addyi® Celebrates 10 Years Leading Women's Sexual Health
    Addyi® Celebrates 10 Years Leading Women's Sexual Health

    04 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/addyi-marks-a-decade-of-leadership-in-womens-sexual-health-302546088.html

    PR NEWSWIRE
    04 Sep 2025
    Share Share
    FDA Prioritizes Addyi® for Low Desire in Postmenopausal Women
    FDA Prioritizes Addyi® for Low Desire in Postmenopausal Women

    24 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-grants-priority-review-for-addyi-flibanserin-paving-the-way-for-expanded-access-to-treat-low-sexual-desire-in-postmenopausal-women-302512883.html

    PR NEWSWIRE
    24 Jul 2025
    Share Share
    Cindy Eckert Wins Ernst & Young Entrepreneur Of The Year® 2025
    Cindy Eckert Wins Ernst & Young Entrepreneur Of The Year® 2025

    27 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cindy-eckert-named-as-an-ernst--young-entrepreneur-of-the-year-2025-southeast-award-winner-for-breaking-barriers-in-womens-sexual-health-302493211.html

    PR NEWSWIRE
    27 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search